CVS Wants Antitrust Suit Over 340B Drug Program Tossed
CVS Pharmacy Inc. and its 340B Drug Pricing Program administrator Wellpartner LLC on Friday urged a Florida federal court to dismiss an antitrust and trade secrets lawsuit brought by a rival...To view the full article, register now.
Already a subscriber? Click here to view full article